History Says Johnson & Johnson Beats Medtronic. Here's Why I'd Still Consider MDT for the Next Decade.
History Says Johnson & Johnson Beats Medtronic. Here's Why I'd Still Consider MDT for the Next Decade. The Motley Fool
Covered in this story
What has happened since
- Medtronic is up 0.9% since this was published, 5 days ago.
- Johnson & Johnson is down 1.7% since this was published, 5 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $MDT yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Medtronic →Summary aggregated from The Motley Fool's public RSS feed. The full reporting belongs to The Motley Fool — please read it on their site.